drug
as of 2026-07-01Memantine XR
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Sheppard Pratt Health System
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Galantamine and Memantine Combination for Cognitive Impairments in Schizophrenia
NCT02234752Phase 2Terminated
KOLs & investigators
1
Maju M. Koola, MDKOL score 6
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
indication
indication
indication
indication
indication
KOL
Maju M. Koola, MD
personKOL score 6